The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency.
Open accessAbstract
Force development and shortening by cardiac muscle occur as a result of the interaction between actin and myosin within the myofibrillar lattice. This interaction is dependent upon intracellular ionized calcium and is controlled by the troponin-tropomyosin regulatory proteins situated along the actin filament. In this study, we compared the myofibrillar content and myofibrillar Mg-ATPase activity of normal human ventricular muscle with that of ventricular muscle from patients in end-stage failure caused by coronary artery disease or cardiomyopathy and ventricular muscle from patients with heart failure due to mitral valve insufficiency. The results show that the amount of myofibrillar protein (mg/g wet wt ventricle) in hearts in end-stage failure (coronary artery disease and cardiomyopathy) is significantly lower compared with normal hearts and hearts in failure due to mitral valve insufficiency. However, the Mg-ATPase activity of myofibrils from hearts in both end-stage failure and failure due to mitral valve insufficiency is significantly lower compared with myofibrils from normal hearts. The data suggest that the reduction in the amount of myofibrillar protein in ventricular tissue is a pivotal event that may be responsible for the progression of heart disease to the point of end-stage failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, the normal range of the systolic/diastolic pulmonary artery pressure is 15–30/4–12 mmHg (Pagani et al., 1988).”
From Thoroughly Calibrated Modular Agent-Based Model of the Human Cardiovascular and Renal Systems for Blood Pressure Regulation in Health and Disease (2021) · cites this paper as Pagani et al., 1988
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
THE COLORIMETRIC DETERMINATION OF PHOSPHORUS
Fiske, C. H., & Subbarow, Y. (1925) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)84756-1 · Cited by 19,155
The colorimetric determination of phosphorus
King, E. J. (1932) · Biochemical Journal · doi:10.1042/bj0260292 · Cited by 1,667
Fabiato, A., & Fabiato, F. (1979) · PubMed · Cited by 1,631
Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles
Swynghedauw, B. (1986) · Physiological Reviews · doi:10.1152/physrev.1986.66.3.710 · Cited by 647
Cardiac hypertrophy: Useful adaptation or pathologic process?
Grossman, W. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90471-4 · Cited by 466
Cardiac catheterization and angiography
(1975) · American Heart Journal · doi:10.1016/0002-8703(75)90525-6 · Cited by 455
Alpha-skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts.
Schwartz, K., Bastie, D. D. L., Bouveret, P., Oliviéro, P., Alonso, S., & BUCKINGHAM, M. E. (1986) · Circulation Research · doi:10.1161/01.res.59.5.551 · Cited by 283
Myosin isoenzymes in normal and hypertrophied human ventricular myocardium.
Mercadier, J.-J., Bouveret, P., Gorza, L., Schiaffino, S., Clark, W. A., Zak, R., Bernard Swynghedauw, A., & Schwartz, K. (1983) · Circulation Research · doi:10.1161/01.res.53.1.52 · Cited by 279
Wikman‐Coffelt, J., Parmley, W. W., & Mason, D. T. (1979) · Circulation Research · doi:10.1161/01.res.45.6.697 · Cited by 276
Research works printed but not linked: 4
- Wikman-Coffelt J, Pannley WW, Mason DT: The cardiac hypertrophy process. Analysis of factors determining patho- logical versus physiological development. Circ Res 1979;45: 697-707
- Fabioto A, Fabioto A: Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for skin cells. J Physiol (Paris) 1979,75:463- 505
- Hammond EH, Anderson JL, Menlove RL: Prognostic significance of myofilament loss in patients with idiopathic cardiomyopathy determined by electron microscopy. J Am Coll Cardiol 1986;7:204A
- Schaper J: Hypertrophy in the human heart: Evaluation by qualitative and quantitative light and electron microscopy, in Alpert NR (ed): Perspectives in Cardiovascular Research. Vol 7 Myocardial Hypertrophy and Failure. New York, Raven Press, Publishers, 1983, pp 177-1%
Cited by
Sorted by citations
Molecular Mechanisms of Myocardial Remodeling
Swynghedauw, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,468
Lowes, B. D., Minobe, W. A., Abraham, W. T., Rizeq, M. N., Bohlmeyer, T. J., Quaife, R. A., Roden, R. L., Dutcher, D. L., Robertson, A. D., Voelkel, N. F., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119770 · Cited by 496
Mercadier, J.-J., Lompré, A., Duc, P., Boheler, K. R., Fraysse, J. B., Wisnewsky, C., Allen, P. D., Michel Komajda, N., & Schwartz, K. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114429 · Cited by 494
Self-citationCongestive Heart Failure: Fifty Years of Progress
Braunwald, E., & Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_4.iv-14 · Cited by 474
Regulation of cardiac contractile function by troponin I phosphorylation
LAYLAND, J., SOLARO, R., & SHAH, A. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.022 · Cited by 385
Anderson, P. A. W., Greig, A., Mark, T. M., Malouf, N. N., Oakeley, A. E., Ungerleider, R. M., Allen, P. D., & Kay, B. K. (1995) · Circulation Research · doi:10.1161/01.res.76.4.681 · Cited by 237
Self-citationTroponin I Phosphorylation in the Normal and Failing Adult Human Heart
Bodor, G. S., Oakeley, A. E., Allen, P. D., Crimmins, D. L., Ladenson, J. H., & Anderson, P. A. W. (1997) · Circulation · doi:10.1161/01.cir.96.5.1495 · Cited by 224
Self-citationAlteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy.
Hasenfuss, G. P., Mulieri, L. A., Leavitt, B. J., Allen, P. D., Haeberle, J. R., & Alpert, N. R. (1992) · Circulation Research · doi:10.1161/01.res.70.6.1225 · Cited by 221
Self-citationHasenfuss, G. P., Mulieri, L. A., Blanchard, E. M., Holubarsch, C., Leavitt, B. J., Ittleman, F. P., & Alpert, N. R. (1991) · Circulation Research · doi:10.1161/01.res.68.3.836 · Cited by 185
Sarcomeric dysfunction in heart failure
Hamdani, N., Kooij, V., van Dijk, S. J., Merkus, D., Paulus, W. J., dos Remedios, C. G., Duncker, D. J., Stienen, G. J. M., & van der Velden, J. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm079 · Cited by 179
Cardiac V 1 And V 3 Myosins Differ in Their Hydrolytic and Mechanical Activities In Vitro
VanBuren, P., Harris, D. E., Alpert, N. R., & Warshaw, D. M. (1995) · Circulation Research · doi:10.1161/01.res.77.2.439 · Cited by 175
Messer, A. E., Jacques, A. M., & Marston, S. B. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.08.017 · Cited by 174
Why does the myocardium fail? Insights from basic science
Bristow, M. R. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90311-7 · Cited by 165
Cardiac Troponin T Isoforms Affect the Ca2+Sensitivity and Inhibition of Force Development
Gomes, A. V., Guzman, G., Zhao, J., & Potter, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204118200 · Cited by 126
Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin.
Mulieri, L. A., Leavitt, B. J., Martin, B. J., Haeberle, J. R., & Alpert, N. R. (1993) · Circulation · doi:10.1161/01.cir.88.6.2700 · Cited by 110
CARDIOVASCULAR AGING IN HEALTH
Lakatta, E. G. (2000) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(05)70021-5 · Cited by 112
Subcellular remodelling may induce cardiac dysfunction in congestive heart failure
Dhalla, N. S., Saini-Chohan, H. K., Rodriguez–Leyva, D., Elimban, V., Dent, M. R., & Tappia, P. S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn281 · Cited by 106
Altered contractile function in heart failure
de Tombe, P. P. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00275-7 · Cited by 103
Differential effects of ovariectomy on calcium activation of cardiac and soleus myofilaments
Wattanapermpool, J., & Reiser, P. J. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.2.h467 · Cited by 95
Regulation of contractile proteins in diabetic heart
Malhotra, A. K. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00059-x · Cited by 94
Kaneko, T., Tanaka, H., Oyamada, M., Kawata, S., & Takamatsu, T. (2000) · Circulation Research · doi:10.1161/01.res.86.10.1093 · Cited by 88
Modulation of Thin Filament Activation by Breakdown or Isoform Switching of Thin Filament Proteins
Marston, S. B., & Redwood, C. S. (2003) · Circulation Research · doi:10.1161/01.res.0000105088.06696.17 · Cited by 86
Hajjar, R. J., & Gwathmey, J. K. (1992) · Circulation · doi:10.1161/01.cir.86.6.1819 · Cited by 86
Myofibrillar remodelling in cardiac hypertrophy, heart failure and cardiomyopathies
Macháčková, J., Barta, J., & Dhalla, N. S. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70315-4 · Cited by 88
Anderson, P. A. W. (1996) · Seminars in Perinatology · doi:10.1016/s0146-0005(96)80064-4 · Cited by 80
Cellular and molecular aspects of contractile dysfunction in heart failure
Mittmann, C. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00139-4 · Cited by 80
Perkins, D. N., Pappin, D., Creasy, D. M., & Cottrell, J. S. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19991201)20:18 · Cited by 8,264
Rowan, R. A., & Billingham, M. E. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90037-6 · Cited by 69
He, X., Liu, Y., Sharma, V. K., Dirksen, R. T., Waugh, R. E., Sheu, S., & Wang, M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63647-4 · Cited by 68
Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy
Schwinger, R. H. G., Böhm, M., & Erdmann, E. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90755-k · Cited by 65
de Tombe, P. P., & Solaro, R. J. (2000) · Annals of Biomedical Engineering · doi:10.1114/1.1312189 · Cited by 61
Mulieri, L. A., Barnes, W., Leavitt, B. J., Ittleman, F. P., LeWinter, M. M., Alpert, N. R., & Maughan, D. W. (2002) · Circulation Research · doi:10.1161/hh0102.103221 · Cited by 61
Thick Filament Proteins and Performance in Human Heart Failure
Palmer, B. M. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-5249-1 · Cited by 58
Myofilament Calcium Regulation in Human Myocardium
Hajjar, R. J., Schwinger, R. H. G., Schmidt, U. H., Kim, C. S., Lebeche, D., Doye, A. A., & Gwathmey, J. K. (2000) · Circulation · doi:10.1161/01.cir.101.14.1679 · Cited by 55
The molecular and cellular pathophysiology of heart failure
Piano, M. R., Bondmass, M. D., & Schwertz, D. W. (1998) · Heart & Lung · doi:10.1016/s0147-9563(98)90063-2 · Cited by 54
Kameyama, T., Chen, Z., Bell, S. P., VanBuren, P., Maughan, D. W., & LeWinter, M. M. (1998) · Circulation · doi:10.1161/01.cir.98.25.2919 · Cited by 49
Schaefer, S., Schwartz, G. G., Steinman, S., Meyerhoff, D. J., Massie, B. M., & Weiner, M. W. (1992) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910250205 · Cited by 48
Cellular and molecular remodeling in a heart failure model treated with the β-blocker carteolol
Gwathmey, J. K., Kim, C. S., Hajjar, R. J., Khan, F., DiSalvo, T. G., Matsumori, A., & Bristow, M. R. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.5.h1678 · Cited by 48
Anderson, P. A. W., Malouf, N. N., Oakeley, A. E., Pagani, E. D., & Allen, P. D. (1992) · Steinkopff eBooks · doi:10.1007/978-3-642-72474-9_10 · Cited by 46
Self-citationElsherif, L., Jiang, Y., Saari, J. T., & Kang, Y. J. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900705 · Cited by 44
Increase in calcium responsiveness of cardiac myofilament activation in ovariectomized rats
Wattanapermpool, J. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00353-1 · Cited by 44
Pelouch, V., Dixon, I., Sethi, R., & Dhalla, N. S. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf00926360 · Cited by 44
Separation and identification of human heart proteins
Jäger, D., Jungblut, P. R., & Müller‐Werdan, U. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00039-9 · Cited by 43
Nguyen, T.-T. T., Hayes, E. S., Mulieri, L. A., Leavitt, B. J., ter Keurs, H. E. D. J., Alpert, N. R., & Warshaw, D. M. (1996) · Circulation Research · doi:10.1161/01.res.79.2.222 · Cited by 42
Knott, A., Purcell, I. F., & Marston, S. B. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.1528 · Cited by 41
Purcell, I. F. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00123-6 · Cited by 40
Functional Consequences of Sarcomeric Protein Abnormalities in Failing Myocardium
LeWinter, M. M. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-5254-4 · Cited by 35
Frank, K. F., Bölck, B., Bavendiek, U., & Schwinger, R. H. G. (1998) · Basic Research in Cardiology · doi:10.1007/s003950050109 · Cited by 35
Alterations of cross-bridge kinetics in human atrial and ventricular myocardium
Ruf, T., Schulte‐Baukloh, H., Lüdemann, J., Posival, H., Beyersdorf, F., Just, H., & Holubarsch, C. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00164-3 · Cited by 34
Development of contractile dysfunction in rat heart failure: hierarchy of cellular events
Daniels, M. C. G., Naya, T., Rundell, V. L. M., & de Tombe, P. P. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00880.2006 · Cited by 33
Role of angiotensin II in the development of subcellular remodeling in heart failure
Bhullar, S. K., Shah, A. K., & Dhalla, N. S. (2021) · Exploration of Medicine · doi:10.37349/emed.2021.00054 · Cited by 31
Alousi, A. A., Grant, A. M., Etzler, J. R., Cofer, B. R., der Bel-Kahn, J. V., & Melvin, D. B. (1990) · Molecular and Cellular Biochemistry · doi:10.1007/bf00228455 · Cited by 30
Self-citationTroponin subunits contribute to altered myosin ATPase activity in diabetic cardiomyopathy
Malhotra, A., Lopez, M. C., & Nakouzi, A. S. (1995) · Molecular and Cellular Biochemistry · doi:10.1007/bf01322339 · Cited by 30
Hajjar, R. J., Liao, R., Young, J. B., Fuleihan, F. J. D., Glass, M., & Gwathmey, J. K. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2212 · Cited by 30
Macháčková, J., Barta, J., & Dhalla, N. S. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-121 · Cited by 25
The force—interval relationship in human myocardium
Schmidt, U. H., Hajjar, R. J., & Gwathmey, J. K. (1995) · Journal of Cardiac Failure · doi:10.1016/1071-9164(95)90006-3 · Cited by 23
Apoptosis-related factors p53, bcl-2 and the defects of force transmission in dilated cardiomyopathy
Tsipis, A., Athanassiadou, A. M., Athanassiadou, P. P., Kavantzas, N., Agrogiannis, G. D., & Patsouris, E. (2010) · Pathology - Research and Practice · doi:10.1016/j.prp.2010.05.007 · Cited by 23
Morano, I. L., Wankerl, M., Böhm, M., Erdmann, E., & Rüegg, J. C. (1989) · Basic Research in Cardiology · doi:10.1007/bf01907977 · Cited by 22
Hasenfuss, G. P., & Just, H. (1994) · Heart · doi:10.1136/hrt.72.2_suppl.s10 · Cited by 22
Effects of Pregabalin on Heart Rate Variability in Patients With Painful Diabetic Neuropathy
Jiang, W., Ladd, S., Martsberger, C., Feinglos, M. N., Spratt, S. E., Kuchibhatla, M. N., Green, J., & Krishnan, R. R. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31820f4f57 · Cited by 21
Thin Filament Remodeling in Failing Myocardium
VanBuren, P., & Okada, Y. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-5250-8 · Cited by 21
Troponin-tropomyosin abnormalities in hamster cardiomyopathy.
Malhotra, A., & Scheuer, J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114697 · Cited by 21
Effects of halothane on contractile properties of skinned fibers from cardiomyopathic animals
Murat, I. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)90675-5 · Cited by 21
Role of regulatory proteins (troponin-tropomyosin) in pathologic states
Malhotra, A. (1994) · Molecular and Cellular Biochemistry · doi:10.1007/bf00925959 · Cited by 19
Role of Subcellular Remodeling in Cardiac Dysfunction due to Congestive Heart Failure
Babick, A. P., & Dhalla, N. S. (2007) · Medical Principles and Practice · doi:10.1159/000098358 · Cited by 19
Myofilament remodeling during the progression of heart failure
LeWinter, M. M., & VanBuren, P. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.129276 · Cited by 19
Margossian, S. S., Anderson, P. A. W., Chantler, P. D., Deziel, M. R., Umeda, P. K., Stafford, W. F., Norton, P., Malhotra, A., Yang, F., Caulfield, J., et al. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006980405359 · Cited by 18
Effect of inotropic interventions on the force-frequency relation in the human heart
Bavendiek, U., Brixius, K., Münch, G., Zobel, C., Müller‐Ehmsen, J., & Schwinger, R. H. G. (1998) · Basic Research in Cardiology · doi:10.1007/s003950050224 · Cited by 18
Hajjar, R. J., Grossman, W., & Gwathmey, J. K. (1992) · Steinkopff eBooks · doi:10.1007/978-3-642-72474-9_12 · Cited by 18
Kutumova, E., Kiselev, I., Sharipov, R., Lifshits, G., & Kolpakov, F. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.746300 · Cited by 16
Saad, N. S., Mashali, M. A., Repas, S. J., & Janssen, P. M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417577 · Cited by 17
Cardiovascular Aging in Health
Boluyt, M. O., & Lakatta, E. G. (1998) · Advances in organ biology · doi:10.1016/s1569-2590(08)60094-4 · Cited by 16
[Ca2+]i in human heart failure: a review and discussion of current areas of controversy.
Liao, R., Helm, P. A., Hajjar, R. J., Saha, C., & Gwathmey, J. K. (1994) · PubMed Central · Cited by 15
Myocardial imaging with 123I-BMIPP in patients with congestive heart failure
Ishida, Y., Yasumura, Y., Nagaya, N., Fukuchi, K., Komamura, K., Takamiya, M., & Miyatake, K. (1999) · International journal of cardiac imaging · doi:10.1023/a:1006152804670 · Cited by 15
Minoxidil-induced cardiac hypertrophy in guinea pigs
van der Velden, J., Borgdorff, P., & Stienen, G. J. M. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050332 · Cited by 14
Altered force-frequency relation in hypertrophic obstructive cardiomyopathy
Schotten, U., Voss, S., Wiederin, T. B., Voss, M., Schöndube, F. A., Hanrath, P., & Schumacher, C. (1999) · Basic Research in Cardiology · doi:10.1007/s003950050134 · Cited by 13
Okafor, C. C., Liao, R., Perreault-Micale, C. L., Li, X., Ito, T., Stepanek, A., Doye, A. A., de Trombe, P., & Gwathmey, J. K. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1022813726734 · Cited by 13
Mathematical modeling of antihypertensive therapy
Kutumova, E. O., Kiselev, I. N., Sharipov, R., Израйлевна, Л. Г., & Kolpakov, F. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1070115 · Cited by 13
Mulieri, L. A., Leavitt, B. J., Wright, R. K., & Alpert, N. R. (1997) · Basic Research in Cardiology · doi:10.1007/bf00794073 · Cited by 12
Kutumova, E. O., Kovaleva, A. Y., Sharipov, R., Израйлевна, Л. Г., & Kolpakov, F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29988 · Cited by 12
MacGowan, G. A., & Koretsky, A. P. (2000) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(00)90017-4 · Cited by 11
Hajjar, R. J. (1991) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(91)90039-o · Cited by 11
Novel cardiac myosin activators for acute heart failure
Bragadeesh, T., Mathur, G., Clark, A. L., & Cleland, J. G. F. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.10.1541 · Cited by 10
Chemomechanical Energy Transduction in the Failing Heart
Alpert, N. R., LeWinter, M. M., Mulieri, L. A., & Hasenfuss, G. P. (1999) · Heart Failure Reviews · doi:10.1023/a:1009818225222 · Cited by 10
Brixius, K., Savvidou-Zaroti, P., Bloch, W., & Schwinger, R. H. G. (2003) · European Journal of Applied Physiology · doi:10.1007/s00421-002-0782-2 · Cited by 10
Age Effects on the Adaptive Response of the Female Rat Heart Following Aortic Constriction
Boluyt, M. O., Devor, S. T., Opiteck, J. A., & White, T. P. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.6.b307 · Cited by 10
Bhullar, S. K., Shah, A. K., & Dhalla, N. S. (2022) · Scripta Medica · doi:10.5937/scriptamed53-36256 · Cited by 8
Peterson, J. N., Nassar, R., Anderson, P. A. W., & Alpert, N. R. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0569c.xd · Cited by 8
Diastolic dysfunction: insights into pathophysiology and pharmacotherapy
Redfield, M. M., & Maniu, C. V. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.6.997 · Cited by 7
Is contractility depressed in the failing human heart?
Gwathmey, J. K., Liao, R., Helm, P. A., Thaiyananthan, G., & Hajjar, R. J. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00878090 · Cited by 7
Torrealba, J. R., Lozano, E., Griffin, M., Stoker, S. W., McDonald, K. S., Greaser, M. L., & Wolff, M. R. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2016 · Cited by 7
Cardiovascular Function During Development and the Response to Hypoxia
Anderson, P. A. W., Kleinman, C. S., Lister, G., & Talner, N. S. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7216-9654-6.50066-7 · Cited by 7
Remme, W. J. (1989) · Cardiovascular Drugs and Therapy · doi:10.1007/bf01858109 · Cited by 7
Human Heart Failure: Determinants of Ventricular Dysfunction
Alpert, N. R., & Mulieri, L. A. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5959-7_9 · Cited by 6
Losartan reduces mortality in a genetic model of heart failure
Günther, S., Baba, H. A., Hauptmann, S., Holzhausen, H.-J., Großmann, C., Punkt, K., Kusche, T., Jones, L. R., Gergs, U., & Neumann, J. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0544-3 · Cited by 6
[Function and role of the sarcoplasmic reticulum in heart disease].
Reyes-Juárez, J. L., & Zarain‐Herzberg, Á. (2006) · PubMed · Cited by 6
Regulation of Cardiac Contraction by Calcium
Moss, R. L., & Buck, S. H. (2002) · Comprehensive physiology · doi:10.1002/cphy.cp020111 · Cited by 6
Structure and function of contractile proteins in human dilated cardiomyopathy
Wiegand, V., Ebecke, M., Figulla, H. R., Schüler, S., & Kreuzer, H. (1989) · Clinical Cardiology · doi:10.1002/clc.4960121108 · Cited by 5
Thin Filament Regulation in Development
Anderson, P. A. W. (2002) · Advances in muscle research · doi:10.1007/978-94-015-9926-9_10 · Cited by 3
Pagani, E. D., O’Connor, B., Allen, P. D., Hille, D. A., & Silver, P. J. (1993) · Drug Development Research · doi:10.1002/ddr.430290305 · Cited by 3
Self-citation
Metadata
- Authors
- Pagani, E. D., Alousi, A. A., Grant, A. M., Older, T. M., Dziuban, S. W., & Allen, P. D.
- Affiliations
- Molecular Cardiology Unit, Sterling-Winthrop Research Institute, Rensselaer, New York 12144.
- ORCID
- Allen, P D
- Venue
- Circulation Research
- Published
- 1988-08
- Volume
- 63
- Issue
- 2
- Pages
- 380-385
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2110787501
- Cited by
- 135
- References
- 27
- Citations by year
- 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2017: 1 · 2014: 2
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- heart failure, Mg2+-ATPase activity, ventricular myocardium, coronary artery disease, cardiomyopathy, mitral regurgitation, end-stage heart failure, actin-myosin interaction
- MeSH terms
- Coronary Disease, Cardiac Catheterization, Heart Failure, Humans, Mitral Valve Insufficiency, Muscle Proteins, Cardiomyopathies, Myocardium, Myofibrils, Reference Values, Ca(2+) Mg(2+)-ATPase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review